DK294489A - Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf - Google Patents

Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf Download PDF

Info

Publication number
DK294489A
DK294489A DK294489A DK294489A DK294489A DK 294489 A DK294489 A DK 294489A DK 294489 A DK294489 A DK 294489A DK 294489 A DK294489 A DK 294489A DK 294489 A DK294489 A DK 294489A
Authority
DK
Denmark
Prior art keywords
salts
buspiron
oral substances
oral
substances
Prior art date
Application number
DK294489A
Other languages
Danish (da)
English (en)
Other versions
DK294489D0 (da
Inventor
Alf Gunnar Martin Nicklasson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of DK294489D0 publication Critical patent/DK294489D0/da
Publication of DK294489A publication Critical patent/DK294489A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK294489A 1987-10-22 1989-06-15 Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf DK294489A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704097A SE8704097D0 (sv) 1987-10-22 1987-10-22 Oral formulation of buspirone and salts thereof
PCT/SE1988/000543 WO1989003676A1 (en) 1987-10-22 1988-10-17 Oral formulation of buspirone and salts thereof

Publications (2)

Publication Number Publication Date
DK294489D0 DK294489D0 (da) 1989-06-15
DK294489A true DK294489A (da) 1989-06-15

Family

ID=20369959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK294489A DK294489A (da) 1987-10-22 1989-06-15 Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf

Country Status (21)

Country Link
EP (1) EP0313535B1 (ja)
JP (1) JP2674170B2 (ja)
KR (1) KR970004906B1 (ja)
AT (1) ATE108997T1 (ja)
AU (1) AU604585B2 (ja)
CY (1) CY1814A (ja)
DE (1) DE3850844T2 (ja)
DK (1) DK294489A (ja)
ES (1) ES2056955T3 (ja)
FI (1) FI100303B (ja)
HK (1) HK21295A (ja)
HU (1) HU204998B (ja)
IE (1) IE64705B1 (ja)
IL (1) IL88020A (ja)
NO (1) NO892512D0 (ja)
NZ (1) NZ226604A (ja)
PT (1) PT88820B (ja)
SE (1) SE8704097D0 (ja)
WO (1) WO1989003676A1 (ja)
YU (1) YU47903B (ja)
ZA (1) ZA887624B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208495B (en) * 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
PL192273B1 (pl) * 1997-09-25 2006-09-29 Bayer Ag Preparat środka leczniczego w postaci pastylki o kontrolowanej dyfuzji lub w postaci układu matrycowego, o kontrolowanym uwalnianiu substancji czynnej
US6268368B1 (en) * 2000-03-01 2001-07-31 American Pharmaceuticals International Anionic exchange polymer complexes of buspirone
CN117257747B (zh) * 2023-11-21 2024-01-30 泊诺(天津)创新医药研究有限公司 一种盐酸丁螺环酮片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
SE353229B (ja) * 1970-06-04 1973-01-29 Haessle Ab
US4182703A (en) * 1978-01-09 1980-01-08 Eastman Kodak Company Biheterocyclic ultraviolet stabilizers and their use in organic compositions
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4634703A (en) * 1985-10-25 1987-01-06 Bristol-Myers Company Method for alleviation of panic disorders
US4640921A (en) * 1986-02-04 1987-02-03 Bristol-Myers Treatment of sexual dysfunction with buspirone

Also Published As

Publication number Publication date
NZ226604A (en) 1991-07-26
ATE108997T1 (de) 1994-08-15
NO892512L (no) 1989-06-16
ZA887624B (en) 1989-06-28
KR890701087A (ko) 1989-12-19
DK294489D0 (da) 1989-06-15
AU604585B2 (en) 1990-12-20
HK21295A (en) 1995-02-24
DE3850844T2 (de) 1994-12-08
NO892512D0 (no) 1989-06-16
AU2623688A (en) 1989-05-23
YU196488A (en) 1990-04-30
YU47903B (sh) 1996-05-20
FI100303B (fi) 1997-11-14
EP0313535B1 (en) 1994-07-27
EP0313535A1 (en) 1989-04-26
PT88820B (pt) 1993-01-29
CY1814A (en) 1995-10-20
SE8704097D0 (sv) 1987-10-22
JPH02501744A (ja) 1990-06-14
FI893017A (fi) 1989-06-20
IL88020A0 (en) 1989-06-30
DE3850844D1 (de) 1994-09-01
HUT54495A (en) 1991-03-28
IL88020A (en) 1993-08-18
WO1989003676A1 (en) 1989-05-05
KR970004906B1 (ko) 1997-04-08
HU204998B (en) 1992-03-30
HU886266D0 (en) 1991-01-28
JP2674170B2 (ja) 1997-11-12
IE64705B1 (en) 1995-08-23
ES2056955T3 (es) 1994-10-16
IE883177L (en) 1989-04-22
FI893017A0 (fi) 1989-06-20

Similar Documents

Publication Publication Date Title
NO174392C (no) Analogifremgangsmåte for fremstilling av acyldeoksyribonukleosidderivater
BR8707937A (pt) Protese para osteosintese
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
DK111387D0 (da) Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
NO883506L (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
DE69206495D1 (de) Matrixtablette zur verlängerten Indapamidfreisetzung nach oraler Gabe.
DK294489A (da) Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DK84089D0 (da) Fremgangsmaade og mellemprodukter til fremstilling af quinolinderivater og farmaceutisk acceptable salte deraf
DK559288A (da) Farmaceutisk praeparat for piperidinoalkanolderivater
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
DK522986D0 (da) Fremgangsmaade til indgift af ethanolaminderivater til husdyr
DK160478A (da) Fremgangsmaade til fremstilling af 3-(1-piperazinyl)-1,2,4-benzotriaziner,n-oxider og pharmaceutisk acceptable salte deraf
ES2041790T3 (es) Derivados de tetrahidroisoquinolina amino-substituidos y su procedimiento de obtencion.
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
MX10256A (es) Procedimiento para preparar nuevas 3-fenil-7h-tiazolo(3, 2-b) (1, 2, 4) triazin-7-onas.
BR6702179U (pt) Articulador para protese dentaria
DK511788D0 (da) Fremgangsmaade til fodring af droevtyggere
IT8722572A0 (it) Apparecchio medicale per iniezione controllata di medicinali.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment